FORGROWTH NAP B.V. sold 1.0% of their position (115.48K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Open‑market sale worth $3.00M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/18/2024ACC: 0000950170-24-137893
10% Owner
Since Jan 2024
-115.48K
Net shares
Net seller
$3.00M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
115.48K disposed
Non-Derivative Transactions3
Ordinary Shares
Indirect
Shares
−1.10K
Price / share
$25.00
Trade value
$27.40K
% of position
0.0%
12/16/2024
11.12M→11.12M
Ordinary Shares
Indirect
Shares
−66.65K
Price / share
$25.60
Trade value
$1.71M
% of position
0.6%
12/17/2024
11.12M→11.06M
Ordinary Shares
Indirect
Shares
−47.74K
Price / share
$26.45
Trade value
$1.26M
% of position
0.4%
12/17/2024
11.06M→11.01M
Total
Net shares
−115.48K
Net value
-$3M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 12/16/2024 | S · Sale | −1.10K | $25.00 | $27.40K | 0.0% | 11.12M | 11.12M |
| Ordinary Shares Indirect | 12/17/2024 | S · Sale | −66.65K | $25.60 | $1.71M | 0.6% | 11.12M | 11.06M |
| Ordinary Shares Indirect | 12/17/2024 | S · Sale | −47.74K | $26.45 | $1.26M | 0.4% | 11.06M | 11.01M |
| Total | −115.48K | -$3M | ||||||
Derivative Transactions0
No derivative transactions reported